1. European Medicines Agency. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. 18 Mar 2021. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots.
2. Covid-19: WHO says rollout of AstraZeneca vaccine should continue, as Europe divides over safety
3. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
4. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis